Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine PR vs Propiverine in Korean OAB Patients
NCT00646880Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolterodine in overactive bladder (OAB), sponsored by Pfizer. Started Mar 2003; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00646880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646880.